Screener
Charles River Laboratories CRL FX & Other Adjustments
FX & Other Adjustments at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | RMS | DSA (1) | Manufacturing (2) | Total |
|---|---|---|---|---|
| December 27, 2025 | $510,844 | $1,678,518 | $574,891 | $2,764,253 |
| Acquisitions | — | 335,906 | 39,786 | 375,692 |
| Divestitures | — | (37,701) | — | (37,701) |
| Foreign exchange | (551) | (19,320) | (5,522) | (25,393) |
| June 27, 2026 | $510,293 | $1,957,403 | $609,155 | $3,076,851 |
| (1) DSA includes accumulated impairment losses of $1 billion, which were recognized in fiscal years 2008 and 2010. | ||||
| (2) Manufacturing includes accumulated impairment losses of $380 million, which were recognized in fiscal years 2024 and 2025. |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's FX & other adjustments?
- Charles River Laboratories (CRL) reported FX & other adjustments of -$6.84M in Q2 2026.
- How has Charles River Laboratories's FX & other adjustments changed year-over-year?
- Charles River Laboratories's FX & other adjustments decreased by 110.9% year-over-year, from $62.86M to -$6.84M.
- What does FX & other adjustments mean?
- The change in the carrying value of goodwill due to fluctuations in foreign exchange rates between the functional currency of the reporting unit and the reporting currency. This is a non-cash adjustment that impacts the balance sheet.
Ask your AI about Charles River Laboratories's fx & other adjustments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude